You are here » Home » Companies » Company Overview » Bacil Pharma Ltd

Bacil Pharma Ltd.

BSE: 524516 Sector: Health care
NSE: N.A. ISIN Code: INE711D01018
BSE LIVE 11:13 | 04 Oct 5.95 0.20
(3.48%)
OPEN

5.95

HIGH

5.95

LOW

5.95

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 5.95
PREVIOUS CLOSE 5.75
VOLUME 15
52-Week high 10.50
52-Week low 5.06
P/E 20.52
Mkt Cap.(Rs cr) 4
Buy Price 0.00
Buy Qty 0.00
Sell Price 5.95
Sell Qty 75.00
OPEN 5.95
CLOSE 5.75
VOLUME 15
52-Week high 10.50
52-Week low 5.06
P/E 20.52
Mkt Cap.(Rs cr) 4
Buy Price 0.00
Buy Qty 0.00
Sell Price 5.95
Sell Qty 75.00

Bacil Pharma Ltd. (BACILPHARMA) - Company History

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).